Connect with us

Tech

China’s first home-grown COVID-19 antibody drug enters commercial market

Avatar

Published

on

China’s first home-grown COVID-19 antibody drug, which showed an efficacy of 80 percent in reducing hospitalizations and deaths in clinical trials, has entered the commercial market, its developer announced Thursday.

The antibody cocktail therapy, made of two monoclonal antibodies Brii-196 and Brii-198, is administered intravenously.

It was jointly developed by a research team from the country’s prestigious Tsinghua University, the Third People’s Hospital of Shenzhen in south China, and Brii Biosciences, the Hong Kong-listed biotech company.

Zhang Linqi, a professor at School of Medicine of Tsinghua University, leads a research team to develop the COVID-19 antibody therapy./Tsinghua University

Last December, the drug was approved by China’s National Medical Products Administration (NMPA) to treat adult and some child patients who are at high risk of developing severe COVID-19.

In March, it was included in the country’s COVID-19 diagnosis and treatment guidelines as a recommended therapy.

The drug will be sold at a price lower than 10,000 yuan (about U.S. $1,494), according to Brii. It has been reportedly added to the reimbursement drug list covered by health insurance in many provinces in China.

Source: CGTN

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Tech

China to improve sci-tech services for rural population

Avatar

Published

on

By

China will launch a national campaign to better mobilize the science and technology sector to contribute to the country’s rural revitalization drive, according to a new set of guidelines.

Jointly issued by the China Association for Science and Technology and the National Rural Revitalization Administration, the guidelines specify a series of key tasks, including providing sci-tech training, lectures and industry-specific guidance to rural areas.

Sci-tech associations at all levels are called on to lead grassroots sci-tech workers to join in the work of rural revitalization.

The guidelines also require the relevant authorities to incorporate the construction of science popularization facilities into the overall layout of rural infrastructure, expand the service coverage of mobile science popularization facilities and build more sci-tech museums in rural secondary schools.

Source: Xinhua

Continue Reading

Tech

China’s Tianzhou-3 cargo spacecraft re-enters Earth’s atmosphere

Avatar

Published

on

By

Tianzhou-3, a cargo spacecraft that carried supplies to China’s space station, made a controlled re-entry into the Earth’s atmosphere at 11:31 a.m. on Wednesday (Beijing Time), according to the China Manned Space Agency.

Tianzhou-3 makes a controlled re-entry into the Earth’s atmosphere, July 27, 2022. /CFP

The Long March-7 Y4 rocket carrying the Tianzhou-3 blasted off at 3:10 p.m. (BJT) on September 20, 2021, from the Wenchang Spacecraft Launch Site in south China’s Hainan Province. It carried about six tonnes of goods, including food items and spacesuits, to the country’s under-construction space station. Six and a half hours later, the cargo spacecraft docked with core module Tianhe at 10:08 p.m. (BJT) on the same day.

A 3D simulation of the Tianzhou-3 cargo spacecraft docking with China’s space station. /China Manned Space Agency

The Tianzhou-3 separated from the space station core module Tianhe on July 17, 2022, after completing all assigned assembly tasks.

It is the third mission of China’s Tianzhou-class unmanned cargo spacecraft and the second resupply mission to the space station after Tianzhou-2.

Source: CGTN

Continue Reading

Tech

Shanghai firm receives urgent monkeypox virus test kit orders from WHO

Avatar

Published

on

By

Shanghai-based ZJ Biotech has received many urgent purchase orders from the World Health Organization (WHO) for its monkeypox virus test kit, and the company is now aiming to provide more support for accurate diagnosis and containment of the disease.

The WHO on Saturday activated its highest alert level for the growing monkeypox outbreak, declaring the virus a Public Health Emergency of International Concern.

The test kit developed by ZJ Biotech can accurately identify monkeypox virus by measuring the gene segment of the virus by specific fluorescence method.

“Currently the best detection method for many infectious pathogens across the world is the nucleic acid test, which has an accuracy rate of over 95 percent. It can reach more than 99 percent for some individual diseases,” said Shao Junbin, chairman of Shanghai ZJ Bio-Tech Co., Ltd.

The monkeypox virus test kit manufactured by the company has been sent to 41 countries and regions around the world. Of these, 24 emergency orders from the WHO were sent to 21 countries, covering Africa, Europe, Oceania and Southeast Asia.

At present, the company is in close contact with the WHO and health institutions in many countries around the world, aiming to provide support for accurate diagnosis and containment of the disease.

Source: CGTN

Continue Reading

Trending